Biallelic inactivation of protoporphyrinogen oxidase and hydroxymethylbilane synthase is associated with liver cancer in acute porphyrias
- 1 March 2015
- journal article
- research article
- Published by Elsevier in Journal of Hepatology
- Vol. 62 (3) , 734-738
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Hepatocellular carcinoma without cirrhosis: think acute hepatic porphyrias and vice versaJournal of Internal Medicine, 2011
- Hemin, an iron‐binding porphyrin, inhibits HIF‐1α induction through its binding with heat shock protein 90International Journal of Cancer, 2011
- Screening for hepatocellular carcinoma in acute intermittent porphyria: a 15-year follow-up in northern SwedenJournal of Internal Medicine, 2010
- Hepatocellular carcinoma: a global viewNature Reviews Gastroenterology & Hepatology, 2010
- PorphyriasThe Lancet, 2010
- Hepatocellular Carcinoma in Variegate Porphyria: A Serious ComplicationActa Dermato-Venereologica, 2010
- Characterization of two missense variants in the hydroxymethylbilane synthase gene in the Israeli population, which differ in their associations with acute intermittent porphyriaMolecular Genetics and Metabolism, 2008
- The novel gene MIA2 acts as a tumour suppressor in hepatocellular carcinomaGut, 2007
- Mutation hotspots in the human porphobilinogen deaminase gene: Recurrent mutations G111R and R173Q occurring at CpG motifsJournal of Inherited Metabolic Disease, 2004
- Porphyrins, porphyrias, cancer and photodynamic therapy — a model for carcinogenesisJournal of Photochemistry and Photobiology B: Biology, 1993